FILE:JNJ/JNJ-8K-20100426164643.txt.gz
EVENTS:	Submission of Matters to a Vote of Security Holders	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Submission of Matters to a Vote of Security Holders
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07.  Submission of Matters to a Vote of Security Holders.
(a)           The annual meeting of the shareholders of the Company was held on April 22, 2010.
(b)           The shareholders elected all the Companys nominees for director and ratified the appointment of PricewaterhouseCoopers LLP as the Companys independent registered accounting firm for the fiscal year 2010.  The shareholders did not approve the shareholder proposal on advisory vote on executive compensation or the shareholder proposal on special shareowner meetings.
1.           Election of Directors:
 
 
 
2.           Ratification of Appointment of PricewaterhouseCoopers LLP:
3.           Shareholder proposal on advisory vote on executive compensation:
4.           Shareholder proposal on special shareowner meetings:
Item 8.01.  Other Events.
On April 22, 2010, the Board of Directors of the Registrant declared a 10.2% increase in the quarterly dividend rate, from $0.49 per share to $0.54 per share of Common Stock.  At the new rate, the indicated dividend on an annual basis is $2.16 per share compared to the previous rate of $1.96 per share.  The next quarterly dividend is payable on June 15, 2010 to shareholders of record as of June 1, 2010.  The Companys related press release is attached to this Report as Exhibit 99.1.
Item 9.01.  Financial Statements and Exhibits.
                                
Exhibit
Description
99.1                      Press release dated April 22, 2010
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
NEW BRUNSWICK, N.J., April 22, 2010 /PRNewswire via COMTEX News Network/--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 10.2% increase in the quarterly dividend rate, from $0.49 per share to $0.54 per share.  The increase was announced this morning at the Annual Meeting of Shareholders in New Brunswick, NJ.
Given our strong financial position and confidence in our ability to deliver outstanding results now and in the future, the Board has voted to increase the dividend for the 48th consecutive year, said William C. Weldon, Chairman and Chief Executive Officer of the Company.
At the new rate, the indicated dividend on an annual basis is $2.16 per share compared to the previous rate of $1.96 per share.  The next quarterly dividend is payable on June 15, 2010 to shareholders of record as of June 1, 2010.
About Johnson & Johnson
Caring for the world, one person at a time...inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 114,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.
(This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995.  These statements are based on current expectations of future events.  If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Johnson & Johnsons expectations and projections.  Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment.  A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnsons Annual Report on Form 10-K for the fiscal year ended January 3, 2010.  Copies of this Form 10-K, as well as subsequent filings, are available online at , or on request from Johnson & Johnson.  Johnson & Johnson does not undertake to update any forward-looking statements as a result of new information or future events or developments.)
www.sec.gov
www.jnj.com


